Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1972 1
1977 1
1979 2
1981 1
1982 3
1983 1
1984 2
1985 4
1986 1
1987 1
1988 3
1990 2
1991 2
1992 1
1993 1
1994 5
1995 2
1996 8
1997 7
1998 4
1999 1
2000 5
2001 7
2002 8
2003 4
2004 7
2005 7
2006 5
2007 4
2008 3
2009 5
2010 9
2011 7
2012 5
2013 8
2014 6
2015 9
2016 11
2017 10
2018 9
2019 6
2020 15
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

193 results
Results by year
Filters applied: . Clear all
Page 1
JCS 2017 Guideline on Management of Vasculitis Syndrome - Digest Version.
Isobe M, Amano K, Arimura Y, Ishizu A, Ito S, Kaname S, Kobayashi S, Komagata Y, Komuro I, Komori K, Takahashi K, Tanemoto K, Hasegawa H, Harigai M, Fujimoto S, Miyazaki T, Miyata T, Yamada H, Yoshida A, Wada T, Inoue Y, Uchida HA, Ota H, Okazaki T, Onimaru M, Kawakami T, Kinouchi R, Kurata A, Kosuge H, Sada KE, Shigematsu K, Suematsu E, Sueyoshi E, Sugihara T, Sugiyama H, Takeno M, Tamura N, Tsutsumino M, Dobashi H, Nakaoka Y, Nagasaka K, Maejima Y, Yoshifuji H, Watanabe Y, Ozaki S, Kimura T, Shigematsu H, Yamauchi-Takihara K, Murohara T, Momomura SI; JCS Joint Working Group. Isobe M, et al. Among authors: nakaoka y. Circ J. 2020 Jan 24;84(2):299-359. doi: 10.1253/circj.CJ-19-0773. Epub 2020 Jan 18. Circ J. 2020. PMID: 31956163 Free article. Review. No abstract available.
Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension.
Hashimoto-Kataoka T, Hosen N, Sonobe T, Arita Y, Yasui T, Masaki T, Minami M, Inagaki T, Miyagawa S, Sawa Y, Murakami M, Kumanogoh A, Yamauchi-Takihara K, Okumura M, Kishimoto T, Komuro I, Shirai M, Sakata Y, Nakaoka Y. Hashimoto-Kataoka T, et al. Among authors: nakaoka y. Proc Natl Acad Sci U S A. 2015 May 19;112(20):E2677-86. doi: 10.1073/pnas.1424774112. Epub 2015 May 4. Proc Natl Acad Sci U S A. 2015. PMID: 25941359 Free PMC article.
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).
Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S, Nomura A, Yoshida S, Nishimoto N. Nakaoka Y, et al. Ann Rheum Dis. 2018 Mar;77(3):348-354. doi: 10.1136/annrheumdis-2017-211878. Epub 2017 Nov 30. Ann Rheum Dis. 2018. PMID: 29191819 Free PMC article. Clinical Trial.
Amelioration of sepsis by TIE2 activation-induced vascular protection.
Han S, Lee SJ, Kim KE, Lee HS, Oh N, Park I, Ko E, Oh SJ, Lee YS, Kim D, Lee S, Lee DH, Lee KH, Chae SY, Lee JH, Kim SJ, Kim HC, Kim S, Kim SH, Kim C, Nakaoka Y, He Y, Augustin HG, Hu J, Song PH, Kim YI, Kim P, Kim I, Koh GY. Han S, et al. Among authors: nakaoka y. Sci Transl Med. 2016 Apr 20;8(335):335ra55. doi: 10.1126/scitranslmed.aad9260. Sci Transl Med. 2016. PMID: 27099174
B38-CAP is a bacteria-derived ACE2-like enzyme that suppresses hypertension and cardiac dysfunction.
Minato T, Nirasawa S, Sato T, Yamaguchi T, Hoshizaki M, Inagaki T, Nakahara K, Yoshihashi T, Ozawa R, Yokota S, Natsui M, Koyota S, Yoshiya T, Yoshizawa-Kumagaye K, Motoyama S, Gotoh T, Nakaoka Y, Penninger JM, Watanabe H, Imai Y, Takahashi S, Kuba K. Minato T, et al. Among authors: nakaoka y. Nat Commun. 2020 Feb 26;11(1):1058. doi: 10.1038/s41467-020-14867-z. Nat Commun. 2020. PMID: 32103002 Free PMC article.
Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
Nakaoka Y, Isobe M, Tanaka Y, Ishii T, Ooka S, Niiro H, Tamura N, Banno S, Yoshifuji H, Sakata Y, Kawakami A, Atsumi T, Furuta S, Kohsaka H, Suzuki K, Hara R, Maejima Y, Tsukamoto H, Takasaki Y, Yamashita K, Okada N, Yamakido S, Takei S, Yokota S, Nishimoto N. Nakaoka Y, et al. Rheumatology (Oxford). 2020 Sep 1;59(9):2427-2434. doi: 10.1093/rheumatology/kez630. Rheumatology (Oxford). 2020. PMID: 31951279 Free PMC article. Clinical Trial.
Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions.
Sugihara T, Hasegawa H, Uchida HA, Yoshifuji H, Watanabe Y, Amiya E, Maejima Y, Konishi M, Murakawa Y, Ogawa N, Furuta S, Katsumata Y, Komagata Y, Naniwa T, Okazaki T, Tanaka Y, Takeuchi T, Nakaoka Y, Arimura Y, Harigai M, Isobe M; Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS). Sugihara T, et al. Among authors: nakaoka y. Arthritis Res Ther. 2020 Apr 7;22(1):72. doi: 10.1186/s13075-020-02171-6. Arthritis Res Ther. 2020. PMID: 32264967 Free PMC article.
Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis.
Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, Kirino Y, Matsuo K, Origuchi T, Shimizu M, Maejima Y, Amiya E, Tamura N, Kawaguchi T, Takahashi M, Setoh K, Ohmura K, Watanabe R, Horita T, Atsumi T, Matsukura M, Miyata T, Kochi Y, Suda T, Tanemoto K, Meguro A, Okada Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Kuwana M, Mizuki N, Tabara Y, Ueda A, Komuro I, Kimura A, Isobe M, Mimori T, Matsuda F. Terao C, et al. Among authors: nakaoka y. Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13045-13050. doi: 10.1073/pnas.1808850115. Epub 2018 Nov 29. Proc Natl Acad Sci U S A. 2018. PMID: 30498034 Free PMC article.
193 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page